Back to top

Chemours: Cyclical Trough Nearing, Margin Strength Supports Buy Rating with Unchanged $26 Price Target

Analyst John McNulty from BMO Capital maintained a Buy rating on Chemours Company and keeping the price target at $26.00. John McNulty has given hi...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

The Chemours Company (CC)